Answers are grounded in this paper and cite their sources.
The hazard of incident cardiovascular disease is higher in those receiving eiASMs. The association is dose dependent and the absolute difference in hazard seems to reach clinical significance by approximately 10 years from first exposure.
No takes yet. Share an insight, caveat, or question.
Josephson et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: